Stockreport

Axovant Tumbles On Failed Drug, But Was Never Part Of The Game Plan [Seeking Alpha]

Axon Enterprise, Inc.  (AXON) 
Last axon enterprise, inc. earnings: 2/7 04:15 pm Check Earnings Report
US:NYSE Investor Relations: investors.axovant.com/investors/sec-filings
PDF Summary Axovant Sciences announced that the phase 2 study using nelotanserin to treat patients with REM sleep behavior disorder has failed to meet on the primary [Read more]